SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2024 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?


To: technetium who wrote (113)8/12/2024 11:35:21 AM
From: technetium  Respond to of 195
 
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”

Jun 3, 2024

Ticker symbol change to take effect on Wednesday, June 5, 2024SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Company will be changing its ticker symbol from “LIFE” to “ATYR.” Effective at the market open on June 5, 2024, the Company’s common stock will trade on the Nasdaq Capital Market under the new symbol “ATYR.”

“As we advance our lead therapeutic candidate, efzofitimod, through a pivotal Phase 3 study in pulmonary sarcoidosis and prepare for potential commercialization, the “ATYR” ticker symbol is a strong reflection of our corporate identity and serves to clarify and enhance our visibility across a broad range of stakeholders,” said Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer of aTyr. “We look forward to this next chapter for ‘ATYR’ as we work to translate tRNA synthetase biology into new therapies for fibrosis and inflammation.”

investors.atyrpharma.com

Thanks to ErikOtto for pointing this out.



To: technetium who wrote (113)8/17/2024 10:09:12 AM
From: technetium1 Recommendation

Recommended By
BulbaMan

  Read Replies (1) | Respond to of 195
 
A great week for the NASDAQ, the biotech composites, AND the contestant portfolios, adding $3.8k to the average portfolio. RVNC was #1 for week (+35%), on buyout offer, but obviously needs to grow more to be positive asset, YTD.

All but one contestant added value this week. And nine are in the black YTD. DEW_DILIGENCE, a big holder in RVNC was top portfolio for the week, and returned to the top eight YTD portfolios in seventh place.













From

To

















Recent

8/9/24

8/16/24

















YTD

12/31/2023









Index Portfolios’ Performance









Symbol

Recent P/L

Recent %

YTD P/L

















^IXIC

$5,904.98

5.3%

$17,455.90

















^NBI

$2,057.91

1.9%

$8,735.89

















^SPSIBI

$2,403.86

2.2%

$9,486.76









Share Performance

Recent Performance

YTD Performance



Top Five



Bottom Five



Top Five



Bottom 5

Symbol

P/L / Initial Price

Symbol

P/L / Initial Price

Symbol

YTD P/L / Initial Price

Symbol

YTD P/L/ Initial Price

RVNC

35.2%

BLUE

-20.8%

HROW

247.5%

CNSP

-99.8%

NVAX

28.3%

SCLP.L

-9.1%

CU6.AX

210.8%

TCON

-97.1%

HROW

26.6%

SERA

-7.6%

VKTX

204.7%

GLYC

-92.4%

STRO

25.4%

KALV

-7.3%

NVAX

170.0%

AMLX

-85.5%

SLDB

24.3%

CLSD

-6.8%

INSM

145.9%

PACB

-84.1%

Average and Median Portfolio Performance



Recent P/L







YTD P/L







Avg.

Median







Avg

Median







$3,801.36

$3,041.57

TRACE I11



$9,512.86

$6,754.90

TECHNETIUM

Top Seven Portfolio Performances

Top Recent Performers

Top YTD Performers

Contestant (Prev. Rank)

Recent P/L

P/L vs. ^SPSIBI

YTD P/L (Rank)

Contestant (Prev. Rank)

YTD P/L

vs. Top Portfolio

P/L vs. ^SPSIBI

Rec. P/L (Rank)

1 - DEW_DILIGENCE (13)

$9,564.82

$7,160.96

$8,668.55 (7)

1 - BULBAMAN (1)

$74,722.27

——

$65,235.51

$4,289.27 (6)

2 - TOMATO (2)

$9,255.02

$6,851.15

$57,025.86 (2)

2 - TOMATO (2)

$57,025.86

$17,696.41

$47,539.10

$9,255.02 (2)

3 - BLADERUNNER (5)

$7,059.85

$4,655.99

$14,209.28 (5)

3 - TRACE I11 (3)

$42,220.42

$32,501.85

$32,733.66

$3,041.57 (9)

4 - STEVE LOKNESS (17)

$5,449.75

$3,045.89

-$6,661.91 (10)

4 - ERIKOTTO (4)

$34,232.86

$40,489.42

$24,746.10

$2,983.06 (10)

5 - TECHNETIUM (4)

$5,325.93

$2,922.07

$6,754.90 (9)

5 - BLADERUNNER (6)

$14,209.28

$60,512.99

$4,722.52

$7,059.85 (3)

6 - BULBAMAN (11)

$4,289.27

$1,885.41

$74,722.27 (1)

6 - ALONER (5)

$13,895.49

$60,826.79

$4,408.73

$803.73 (16)

7 - RAJU_BIJLEE (6)

$4,208.52

$1,804.66

$7,032.52 (8)

7 - DEW_DILIGENCE (9)

$8,668.55

$66,053.72

-$818.21

$9,564.82 (1)

8 - KATHLEEN (9)

$3,278.43

$874.56

-$9,533.43 (14)

8 - RAJU_BIJLEE (7)

$7,032.52

$67,689.75

-$2,454.24

$4,208.52 (7)

9 - TRACE I11 (1)

$3,041.57

$637.70

$42,220.42 (3)

9 - TECHNETIUM (8)

$6,754.90

$67,967.37

-$2,731.86

$5,325.93 (5)

Top Portfolios’ Contents

Top Recent Performance Portfolio (DEW_DILIGENCE)

Top YTD Performance Portfolio (BULBAMAN)

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

AVIR

6.25%

6.5% | 13.4%

$841.31

$599.52

14.1%

CU6.AX

20.00%

35.6% | 210.8%

$42,161.03

$1,711.87

1.6%

BNTX

6.25%

4.8% | -16.7%

-$1,048.67

$269.35

19.1%

CYTH

10.00%

4.5% | -20.8%

-$2,075.47

-$62.89

12.6%

ENTA

25.00%

28.3% | 22.7%

$5,694.51

-$959.24

3.2%

LRMR

10.00%

9.5% | 66.8%

$6,681.32

-$197.80

6.0%

FRLN

0.00%

0.0% | 2.0%

$408.16

$0.00

----

PMN

10.00%

6.2% | 8.7%

$869.57

$260.87

9.2%

MRNA

6.25%

5.2% | -10.1%

-$636.19

$124.03

17.7%

SNGX

10.00%

1.8% | -68.8%

-$6,875.00

$542.76

32.0%

RVNC

25.00%

19.5% | -15.6%

-$3,909.61

$9,891.93

4.7%

TCON

10.00%

0.2% | -97.1%

-$9,714.45

-$3.71

350.2%

VIR

25.00%

19.7% | -14.6%

-$3,665.78

-$223.81

4.7%

TLX.AX

15.00%

16.0% | 86.4%

$12,965.99

$2,400.88

3.6%

VKTX

6.25%

15.9% | 175.0%

$10,984.82

-$136.96

5.8%

VKTX

15.00%

26.2% | 204.7%

$30,709.30

-$362.71

2.2%